In the 21st century investor’s toolkit, there are dozens of gauges investors can use to track stocks. A duo of the best are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite fund managers can outclass their index-focused peers by a solid amount (see just how much).
Equally as key, optimistic insider trading sentiment is a second way to look at the marketplace. Obviously, there are lots of motivations for an insider to cut shares of his or her company, but only one, very simple reason why they would buy. Plenty of empirical studies have demonstrated the impressive potential of this strategy if investors know where to look (learn more here).
Furthermore, let’s discuss the latest info surrounding Biomed Realty Trust Inc (NYSE:BMR).
What have hedge funds been doing with Biomed Realty Trust Inc (NYSE:BMR)?
Heading into Q3, a total of 15 of the hedge funds we track were long in this stock, a change of -17% from the first quarter. With hedge funds’ capital changing hands, there exists a select group of key hedge fund managers who were upping their stakes significantly.
When using filings from the hedgies we track, Jeffrey Furber’s AEW Capital Management had the biggest position in Biomed Realty Trust Inc (NYSE:BMR), worth close to $55.4 million, accounting for 1.4% of its total 13F portfolio. Sitting at the No. 2 spot is Fisher Asset Management, managed by Ken Fisher, which held a $47.5 million position; 0.1% of its 13F portfolio is allocated to the company. Some other peers that are bullish include J. Alan Reid, Jr.’s Forward Management, D. E. Shaw’s D E Shaw and Israel Englander’s Millennium Management.
Because Biomed Realty Trust Inc (NYSE:BMR) has experienced declining interest from the smart money’s best and brightest, it’s safe to say that there lies a certain “tier” of funds that decided to sell off their entire stakes heading into Q2. Intriguingly, Matthew Hulsizer’s PEAK6 Capital Management sold off the largest stake of all the hedgies we track, valued at about $5.3 million in stock. Peter Rathjens, Bruce Clarke and John Campbell’s fund, Arrowstreet Capital, also sold off its stock, about $4.3 million worth. These transactions are intriguing to say the least, as aggregate hedge fund interest fell by 3 funds heading into Q2.
What have insiders been doing with Biomed Realty Trust Inc (NYSE:BMR)?
Insider buying is most useful when the company in question has experienced transactions within the past 180 days. Over the latest six-month time period, Biomed Realty Trust Inc (NYSE:BMR) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).
We’ll go over the relationship between both of these indicators in other stocks similar to Biomed Realty Trust Inc (NYSE:BMR). These stocks are Sovran Self Storage Inc (NYSE:SSS), DCT Industrial Trust Inc. (NYSE:DCT), CubeSmart (NYSE:CUBE), Duke Realty Corp (NYSE:DRE), and Extra Space Storage, Inc. (NYSE:EXR). All of these stocks are in the reit – industrial industry and their market caps resemble BMR’s market cap.